Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06180551 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Homburg Renal Evaluation Study on the Clinical Utility of Early AKI Diagnosis

Study acronym: RESCUE-AKI
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Critically ill patients are at risk of developing a sudden decrease of kidney function which may be detected by a decrease in urine output or is diagnosed on the basis of blood tests for substances normally eliminated by the kidney, primarily creatinine. Because it takes about 24 hours for the creatinine level to rise, even if both kidneys have ceased to function, better markers are needed. This trial is investigating if the marker urinary dickkopf-3 (uDKK3) allows an early prediction of a sudden decrease of kidney function.
Trial Details
NCT Number NCT06180551
Lead Sponsor Universität des Saarlandes
Conditions
(from sponsor)		 Acute Kidney Injury
Related terms Acute Kidney Injury
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov